| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $46.0M | +31.8% |
| R&D Expense | $18.8M | +2.7% |
| SG&A Expense | $30.7M | +13.5% |
| Operating Income | -$54.3M | -29.0% |
| Interest Expense | $2.6M | -26.4% |
| Pre-tax Income | -$61.4M | -34.4% |
| Income Tax | $45K | +40.6% |
| Net Income | -$61.4M | -34.4% |
| EPS (Basic) | -$0.71 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.0M | -67.4% |
| Accounts Receivable | $7.2M | +46.0% |
| Inventory | $4.3M | +40.5% |
| Current Assets | $19.9M | -21.3% |
| Total Assets | $82.5M | -10.5% |
| Current Liabilities | $18.2M | +5.7% |
| Long-term Debt | $15.9M | -39.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$32.5M | +0.5% |
| Investing Cash Flow | -$9.4M | -3570.4% |
| Financing Cash Flow | $31.5M | -31.0% |
| +1.4% |
| Total Liabilities |
| $48.3M |
| -17.8% |
| Stockholders' Equity | $34.1M | +2.3% |